IceCure Medical outlines post-market study plan for ProSense amid FDA engagement and prepares for US commercial launch
https://seekingalpha.com/news/4453185-icecure-medical-outlines-post-market-study-plan-for-prosense-amid-fda-engagement-and-prepares?source=feed_tag_israel
May 28, 2025 -
0
UnitedHealth posts worst monthly drop since 2009 amid negative headlines
https://seekingalpha.com/news/4454042-unitedhealth-stock-posts-worst-monthly-drop-in-years?source=feed_sector_healthcare
May 31, 2025 -
0
J&J posts late-stage trial win for PARP inhibitor combo in prostate cancer
https://seekingalpha.com/news/4454913-jj-wins-phase-3-trial-prostate-cancer-dru?source=feed_sector_healthcare
Jun 03, 2025 -
0
Crude oil posts strongest weekly gain this year on renewed U.S.-China optimism
https://seekingalpha.com/news/4456344-crude-oil-posts-strongest-weekly-gain-this-year-on-renewed-us-china-optimism?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Jun 06, 2025 -
0
TCHP: Huge Bounce Back Post Liberation Day, Upgrading To Hold
https://seekingalpha.com/article/4794206-tchp-etf-huge-bounce-back-post-liberation-day-upgrading-to-hold?source=feed_tag_etf_portfolio_strategy
Jun 11, 2025 -
0
Wall Street’s rally stalls as US stocks post their 1st loss in 4 days
https://www.sandiegouniontribune.com/2025/06/11/stock-market-us-china-framework/
Jun 11, 2025 - The S&P 500 slipped 0.3% Wednesday.
0
Somnigroup: Investors Remain Cautious Post Multi-Billion Dollar Deal (Technical Analysis)
https://seekingalpha.com/article/4795565-somnigroup-investors-remain-cautious-post-multi-billion-dollar-deal-technical-analysis?source=feed_all_articles
Jun 17, 2025 -
0
Musk’s X sues New York over requirement to show how social media platforms handle problematic posts
https://www.sandiegouniontribune.com/2025/06/17/content-moderation-lawsuit/
Jun 17, 2025 - The New York law requires reports on how social media platforms handle problematic posts.
0
Vertex posts additional trial data for type 1 diabetes therapy
https://seekingalpha.com/news/4460532-vertex-posts-new-trial-data-type-1-diabetes-drug?source=feed_sector_healthcare
Jun 21, 2025 -
0
Eli Lilly posts detailed late-stage trial data for oral weight loss drug orforglipron
https://seekingalpha.com/news/4460539-eli-lilly-posts-trial-data-oral-obesity-drug?source=feed_sector_healthcare
Jun 21, 2025 -
0